Barinthus Biotherapeutics plc (BRNS) Tops Q2 EPS by 2c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• PG&E Corp, Edison Spike; California Assembly Won't Take Vote On Utility Wildfire Bill
• Meta Disables Cameras on Some Tampered Smart Glasses - Semafor
• LP Building Solutions to halt OSB output at Texas plant in October